Lexaria Bioscience Corp.
- LEXX
- NASDAQ
- Biotechnology
- Drug Delivery Technology (DehydraTECH)
- Biotech (Pharmaceutical Enhancement)
$2.65
Today +1.92%Quote Oct 20, 2026, 08:00 PM UTC
−22.63%over the last month
Max drawdown −24.9%From 1-month high −23.4%3 months −68.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Lexaria Bioscience
Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
7
Founded
2004
Market value
$65.7M
Quote Oct 20
Analyst target
$1.50
−43.4% from here
Floor
$2.43
8.3% below price
Resistance
$2.97
12.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LEXXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free